Explorer
Vaccine approval is premature & could be dangerous: Shashi Tharoor
Shashi Tharoor tweeted, "The Covaxin has not yet had Phase 3 trials. Approval was premature and could be dangerous. Dr. Harsh Vardhan should please clarify. Its use should be avoided till full trials are over. India can start with the AstraZeneca vaccine in the meantime".
Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use.
Watch the video to know more.
Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use.
Watch the video to know more.
India
Breaking: Dalit Leader Defends Haldwani Ground Purification, Rejects Claims of Targeting Kharge
BIG UPDATE: Census 2027 Form Lists Caste Question Alongside SC, ST Details in 40-Point Schedule
POLITICAL ROW: Rahul Gandhi's PM Modi Mimicry Sparks BJP Outrage Over Foreign Policy Remarks
Breaking: Jhansi Hoarding Row Escalates as BJP and SP Workers Trade Sharp Allegations
POLITICAL ROW: Haldwani Stage Purification Sparks Dalit Debate After Kharge Rally
View More
Trending News




















